This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In this episode, I’ll discuss why vaccines aren’t given in the 14 days after non-elective splenectomy. Better functional antibody responses against the serogroup and serotypes studied seemed to occur with delayed (14-day) vaccination. There is no data to assist with decision making in this scenario.
In this episode, I’ll discuss why the quadrivalent meningococcal vaccine was used as a control for a COVID-19 vaccine. Episode 548: Why was the quadrivalent meningococcal vaccine used as a control for a COVID-19 vaccine? The delivery of this spike protein then causes the immunogenicity to the virus to develop.
In this episode, I’ll discuss why vaccines aren’t given in the 14 days after non-elective splenectomy. Better functional antibody responses against the serogroup and serotypes studied seemed to occur with delayed (14-day) vaccination. There is no data to assist with decision making in this scenario.
In this episode, I’ll discuss the CDC Recommendations if a patient develops COVID-19 before receiving the 2nd vaccine dose. Patients who get COVID-19 before their 2nd vaccine dose and are treated with a monoclonal antibody, and 2. This guidance also applies to people who get COVID-19 before getting their second dose of vaccine.
In this episode, I’ll discuss a possible syndrome that might herald vaccine-induced immune thrombotic thrombocytopenia. Episode 646: Does vaccine-induced immune thrombotic thrombocytopenia have a “pre-VITT syndrome” ? All 11 patients presented with severe headache 5 to 18 days after adenovirus vector vaccination.
Materials and Methods The primary objective was to compare the FN rate within 20 days of chemotherapy administration in patients who received a CSF during inpatient admission and had a transportation barrier to health care (group 1) vs patients without a transportation barrier to health care (group 2). HOPA has selected 4.0
Market Basket and Payment Rate Updates Hospital Inpatient Prospective Payment System Operating and Capital Payment Rate Updates The NHC is concerned about whether CMS’ proposed 2.4 5 A coordinated assessment of these methodologies is essential to avoid creating new disparities in Medicare inpatient payments.
During the pandemic, many consumers received Covid-19 testing and vaccines at pharmacies, helping to normalise the notion that such places could serve as a point-of-care provider. For example, in Indonesia, as per Halodoc, women are more likely to see outpatient doctors compared to men but spend less on average for inpatient services.
Below is a quick summary to help your eligible patients prepare: Medicare Part A: Hospital insurance that includes inpatient and overnight hospital care, skilled nursing facility services, nursing home care, hospice care, and home health services. Part D plans will also cover most vaccines, except for those covered in Part B.
Related Videos Related Content Advertisement June 11th 2025 Perioperative Nivolumab Shows Long-Term EFS, Favorable OS in Resectable NSCLC Luke Halpern, Assistant Editor June 3rd 2025 S2.
Related Videos Related Content Advertisement June 10th 2025 Inpatient Biosimilar Use Grows, Offering Cost-Saving Opportunities for Health Systems Aislinn Antrim, Managing Editor June 3rd 2025 S2. December 21, 2004. Subscribe Now!
Breakdown of Medicare Types and Coverage Below is a quick summary to help your eligible patients prepare: Medicare Part A: Hospital insurance that includes inpatient and overnight hospital care, skilled nursing facility services, nursing home care, hospice care, and home health services.
Related Videos Related Content Advertisement June 16th 2025 Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor Adam Musante, PharmD Marissa Aquino, PharmD Meredith Vigneaux, PharmD June 3rd 2025 S2. HOPA has selected 4.0 Additional information is available here.
Traditionally administered in inpatient or observation settings due to concerns of cytokine release syndrome (CRS) and other acute toxicities, step-up dosing (SUD) regimens have emerged as a strategy to mitigate these risks.
This could become of clinical significance in the administration of vaccines, benzodiazepines, and antipsychotics. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–
More patients are preferring to receive infused medications in the comfort of their homes instead of inpatient settings. Medical assistants need training to administer vaccines. Home Infusion Administration The demand for in-home infusion treatments is growing. You need an active RN license and infusion experience to qualify.
This could become of clinical significance in the administration of vaccines, benzodiazepines, and antipsychotics. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–
Related Videos Related Content Advertisement June 16th 2025 Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor Adam Musante, PharmD Marissa Aquino, PharmD Meredith Vigneaux, PharmD June 3rd 2025 S2.
Another rejected proposal was a definition of “vaccine” (vaccines are exempt from Medicaid rebates), which would have limited this term to a product that is administered prophylactically – i.e., to prevent rather than treat a disease. 1396r-8(k)(3).
Recommendations on who should receive tetanus immune globulin as post-exposure prophylaxis are those patients with less than 3 or an unknown number of tetanus vaccines and a dirty/contaminated wound. If the patient is also receiving a tetanus vaccine, separate syringes and different anatomical sites must be used for each injection.
Pneumococcal disease remains a global threat, with vaccines recommended for at-risk groups, including children. Economic value assessments of pneumococcal vaccination are underreported, highlighting the need for updated utility studies.
Inpatient Pharmacy Services Explain Floor stock, unit of dose and unit of use High alert medications Tall man lettering, sound-alike medication, look-alike medication Standard and end user item Floor stock list - How to decide min and max level List non-medical items that should be available in the emergency trolley.
Recommendations on who should receive tetanus immune globulin as post-exposure prophylaxis are those patients with less than 3 or an unknown number of tetanus vaccines and a dirty/contaminated wound. If the patient is also receiving a tetanus vaccine, separate syringes and different anatomical sites must be used for each injection.
The rabies vaccine produces active immunity beginning about 7 to 10 days after the vaccine series is started. Because the half-life of RIG is about 3 weeks, the passive immunity lasts long enough until active immunity via vaccine response can be generated. The dose of RIG is 20 units/kg x 1.
And then into the outpatient and inpatient settings—are we treating the right patients in the inpatient setting that need to be treated? Then we filter that all the way down into the clinic, about how do we, you know, move patients in and out of the system? How are we advanced prepping drugs? Are we making sure things are going well?
In this episode, I’ll discuss the available safety and efficacy data of Pfizer’s Covid-19 vaccine. A fact sheet for the vaccine is available from the FDA here. 43,548 patients were divided evenly between the vaccine and placebo groups. The vaccine overall was 95% effective.
It is the third positive pivotal trial for the antibody, coming after the MELODY study showed that the drug was able to reduce lower respiratory tract infections requiring medical attention – either inpatient or outpatient – due to RSV in healthy preterm and term infants. Last year, sales were around $320 million.
No interim analysis had been performed and blinding was maintained prior to the study being stopped but the study protocol no longer fit into real-world practice given the widespread use of vaccination and monoclonal antibodies.
- Discussing the 4 main drug targets Functional Groups - Quick refresh on IUPAC nomenclature Drug Potency - Refresh on drug potency Drug Metabolism - Discussing Phase I and II reactions, as well as CYP450 system Pharmacogenomics - Discussing some examples Miscellaneous Continuous Professional Development - Needed for renewal of annual retention Immunization (..)
5 The Most Significant Driver of Health Care Spend Isn’t Drugs—It Isn’t Even Close Pharmaceutical manufacturers are a frequent punching bag for politicians, mostly because they are easy targets, and they tend to have more visible out-of-pocket exposure.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content